Athanasios T. Skoutelis - Infectious Diseases

Author Information

Athanasios T. Skoutelis is affiliated with the 5th Department of Medicine and Infectious Diseases at Evaggelismos General Hospital in Athens, Greece. His work primarily focuses on infectious diseases, with notable contributions in the treatment and surveillance of infections such as HIV, candidemia, and central line-associated bloodstream infections.

Research Contributions

Athanasios T. Skoutelis has been actively involved in research concerning the management and treatment of infectious diseases. His work includes significant studies on HIV transmission and treatment strategies, particularly in Greece. He has also contributed to clinical trials like the STRIVE trial, comparing the efficacy of antifungal treatments for candidemia and invasive candidiasis. His research extends to antimicrobial prophylaxis in surgical settings and the surveillance of bloodstream infections, especially among pediatric patients.

Aliases

Athanasios T. Skoutelis is also known by several variations of his name in academic publications. These include A T Skoutelis, A. T. Skoutelis, Athanasios T Skoutelis, A Skoutelis, A.t. Skoutelis, and Athanasios Skoutelis.

Publication and Citation Metrics

Metric	Value
Total Citations	3903
h-index	32
Total Papers	138

Publications:

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

DOI: 10.1136/sextrans-2020-054509

Year: 2020

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

DOI: 10.1093/cid/ciaa1380

Year: 2020

Perioperative antimicrobial prophylaxis in adult patients: The first multicenter clinical practice audit with intervention in Greek surgical departments

DOI: 10.1017/ice.2020.1276

Year: 2020

Establishing nationally representative central line-associated bloodstream infection surveillance data for paediatric patients in Greece.

DOI: 10.1016/j.jhin.2018.07.032

Year: 2019

Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention

DOI: 10.1080/09540121.2019.1601671

Year: 2019

HIV cascade of care in Greece: Useful insights from additional stages

DOI: 10.1371/journal.pone.0207355

Year: 2018

HIV testing history and access to treatment among migrants living with HIV in Europe

DOI: 10.1002/jia2.25123

Year: 2018

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

DOI: 10.1016/S2352-3018(18)30003-1

Year: 2018

Lymphocutaneous nocardiosis in a kidney transplant patient successfully treated with tigecycline.

DOI: 10.4103/1319-2442.243954

Year: 2018

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

DOI: 10.1093/OFID/OFY209.124

Year: 2018

What are the Challenges in Infectious Disease Education?

How Does the FDA Address Antibiotic Resistance?

How are Zoonoses Transmitted?

What is Parasite DNA?

What Are the Limitations of Throat Swabs?

How is ARDS Diagnosed?

What are HIV Antivirals?

What is the global impact of Dengvaxia?

How Are Muscle Aches Diagnosed?

What Are the Common Concerns About Vaccines?

Partnered Content Networks

Relevant Topics